个人简历

教育背景
2002.9–2006.7 苏州大学 生物技术
2003.8–2005.7 Troy state university 细胞和分子生物学 学士
2007.9–2010.7 南开大学 微生物 硕士
2012.7–2015.9 天津医科大学 临床检验诊断学 博士
2013.3–2014.2 University of Pennsylvania医学院 转化医学中心 博士
工作经历
2013.1- 天津医科大学 医学检验学院 讲师
2010.9-2012.12 天津医科大学 医学检验学院 助教
荣誉奖励
2011年天津医科大学青年教师讲课大赛二等奖
2015年度天津市“131”创新型人才培养工程第三层次人选

研究领域

肿瘤诊断与靶向治疗

近期论文

1. HuijingBao, Chengfeng Bi, Wei Li, Xuhan Zhang,Huilai Zhang, Bin Meng and KaiFu*.Chimeric Antigen Receptor-Engineered Exosome As a Drug Delivery System in Mantle Cell Lymphoma. 59th Annual Meeting and Exposition, Atlanta, GA. Blood, December 9-12, 2017,pub
2. Qin Yuan, Jiayin Song, Weiwei Yang, Hongyan Wang, QianyuHuo, Jie Yang, Xiaoxu Yu, Yunde Liu, Chen Xu and HuijingBao*. The effect of CA125 on metastasis of ovarian cancer: Old marker new function. Oncotarget. 2017.06.17. doi: 10.18632/oncotarget.1838
3. Xiaopeng Yuan，Mingjuan Yang，Xiang Chen，Xuhua Zhang，ShreySukhadia，NajiaMusolino，HuijingBao，Tingtao Chen，Chen Xu，Qirui Wang，Stephen Santoro，Daniel Ricklin，Jia Hu，Ruihe Lin，Wei Yang，Zhijun Li，Weijun Qin，Aizhi Zhao，Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy，Cancer Immunology, Immunotherapy，2016.12.08，s00262：016~1937
4. Chen Xu，Nan Zhang，QianyuHuo，Minghui Chen，Rengfeng Wang，Zhili Liu，Xue Li，Yunde Liu，HuijingBao*. Polymerase chain reaction–hybridization method using urease gene sequences for high-throughput Ureaplasmaurealyticum and Ureaplasmaparvum detection and differentiation，Analytical Biochemistry，2016.2.25，499：57~62
5.HuijingBao, Xiaoxu Yu, Chen Xu, Xue Li, et al. New Toxicity Mechanism of Silver Nanoparticles: Promoting Apoptosis and Inhibiting Proliferation. PloS One. 2015 Mar 30 10(3)
6. Yu Qin, HuijingBao(co-first author), Yi Pan, et al. SUMOylation alterations are associatedwith multidrug resistance in hepatocellular carcinoma. molecular medicine reports 9:877-881,2014